The 32nd ECTRIMS congress will take place from Wednesday 14 September to Saturday 17 September 2016 in London, United Kingdom (ExCeL Centre, a modern state-of- the-art facility in east London and close by the London City Airport, www.excel-london.co.uk).
The 2016 Congress will be the first ever held in the United Kingdom, a country that has contributed much to research and treatment in MS. Many excellent UK-based scientists and clinicians have focused their career on MS and it is indeed timely that the United Kingdom will host an ECTRIMS Congress. The meeting will also partner with the Annual Conference of Rehabilitation in MS (RIMS).
The Congress is offering comprehensive scientific and teaching programmes. An exciting scientific programme has been developed by the Local Organising and Scientific Programme Committees. There will be plenary, platform, young investigator, hot topic (some in a debate format) and poster sessions. Themes will include disease mechanisms, prognostic markers, developments in imaging, and approaches to early treatment, long term treatment effects, the latest clinical trial results, and emerging targets for modulation of the innate immune system, neuroprotection and repair. While MS is the main focus, there will be talks on other inflammatory demyelinating CNS diseases. There will be a special section of the programme for MS nurses and symposia sponsored by the European Charcot Foundation and industry.
A total of 1985 abstracts were submitted for this year’s congress, the largest number ever submitted to any ECTRIMS congress and 10% higher than the last year’s number. This sets the scene for another exciting congress congress at which new findings will be reported in posters and oral presentations on a wide variety of clinical and scientific topics. Abstract reviewing is in progress and authors will hear the outcome in late June. The deadline for submission of late breaking news abstracts is 4 July 2016.